| PRIVILEDGE - ALPHA JAPAN (JPY) N CAP | RVI JAPÓN | 31,08% | 64,29% | 66,19% | 186,96% |
| MAINFIRST - GLOBAL EQUITIES UNCONSTRAINED FUND A EUR CAP | RVI GLOBAL | 30,88% | 83,41% | 66,18% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | RVI BIOTECNOLOGÍA | 65,91% | 59,38% | 66,17% | 201,74% |
| JPM GLOBAL SELECT EQUITY I2 (ACC) USD | RVI GLOBAL | 13,09% | 44,26% | 66,17% | · |
| JPMORGAN ETFS(IRL)ICAV-GLOBAL EQUITY MULTI-FACTOR UCITS ETF USD (ACC) | RVI GLOBAL | 24,93% | 52,56% | 66,17% | · |
| AXA IM GLOBAL EQUITY QI B EUR ACC | RVI GLOBAL | 22,76% | 55,69% | 66,15% | 179,35% |
| LOOMIS SAYLES U.S. GROWTH EQUITY I/A (EUR) | RVI USA CRECIMIENTO | 2,69% | 47,66% | 66,15% | · |
| SCHRODER ISF JAPANESE OPPORTUNITIES I DIS JPY | RVI JAPÓN VALOR | 42,90% | 63,46% | 66,14% | 129,17% |
| INVESCO EURO EQUITY A CAP EUR | RV EURO | 25,07% | 51,11% | 66,13% | 146,94% |
| UBS MSCI UNITED KINGDOM UCITS ETF HEUR ACC | RVI UK | 22,30% | 48,28% | 66,13% | · |
